rs63390262

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BS1BS2

This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Pro387Leu (NM_004992.3) variant in MECP2 is 0.026% in South Asian sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Pro387Leu variant is observed in at least 2 unaffected individuals (PMID 12161600, GeneDx internal database) (BS2). In summary, the p.Pro387Leu variant in MECP2 is classified as benign based on the ACMG/AMP criteria (BS1, BS2). LINK:https://erepo.genome.network/evrepo/ui/classification/CA170185/MONDO:0010726/016

Frequency

Genomes: 𝑓 0.000083 ( 0 hom., 3 hem., cov: 20)
Exomes 𝑓: 0.000067 ( 0 hom. 31 hem. )
Failed GnomAD Quality Control

Consequence

MECP2
NM_001110792.2 missense

Scores

1
7
9

Clinical Significance

Benign reviewed by expert panel U:2B:8

Conservation

PhyloP100: 2.66
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BS1
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MECP2NM_001110792.2 linkc.1196C>T p.Pro399Leu missense_variant Exon 3 of 3 ENST00000453960.7 NP_001104262.1 P51608-2A0A140VKC4Q59FJ6
MECP2NM_004992.4 linkc.1160C>T p.Pro387Leu missense_variant Exon 4 of 4 ENST00000303391.11 NP_004983.1 P51608-1D3YJ43Q59FJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MECP2ENST00000453960.7 linkc.1196C>T p.Pro399Leu missense_variant Exon 3 of 3 1 NM_001110792.2 ENSP00000395535.2 P51608-2
MECP2ENST00000303391.11 linkc.1160C>T p.Pro387Leu missense_variant Exon 4 of 4 1 NM_004992.4 ENSP00000301948.6 P51608-1

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
9
AN:
108861
Hom.:
0
Cov.:
20
AF XY:
0.0000964
AC XY:
3
AN XY:
31119
FAILED QC
Gnomad AFR
AF:
0.000168
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000404
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000577
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000752
AC:
13
AN:
172961
Hom.:
0
AF XY:
0.0000948
AC XY:
6
AN XY:
63267
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000265
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000651
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000671
AC:
73
AN:
1088299
Hom.:
0
Cov.:
36
AF XY:
0.0000870
AC XY:
31
AN XY:
356327
show subpopulations
Gnomad4 AFR exome
AF:
0.0000762
Gnomad4 AMR exome
AF:
0.0000854
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000241
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000633
Gnomad4 OTH exome
AF:
0.0000437
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000826
AC:
9
AN:
108906
Hom.:
0
Cov.:
20
AF XY:
0.0000962
AC XY:
3
AN XY:
31174
show subpopulations
Gnomad4 AFR
AF:
0.000167
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000406
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000577
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000142
Hom.:
1
Bravo
AF:
0.0000491
ExAC
AF:
0.0000993
AC:
12

ClinVar

Significance: Benign
Submissions summary: Uncertain:2Benign:8
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Rett syndrome Benign:2
Dec 13, 2021
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
Significance: Benign
Review Status: reviewed by expert panel
Collection Method: curation

The allele frequency of the p.Pro387Leu (NM_004992.3) variant in MECP2 is 0.026% in South Asian sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Pro387Leu variant is observed in at least 2 unaffected individuals (PMID 12161600, GeneDx internal database) (BS2). In summary, the p.Pro387Leu variant in MECP2 is classified as benign based on the ACMG/AMP criteria (BS1, BS2). -

Sep 25, 2023
Centre for Population Genomics, CPG
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: curation

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 2.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is between 0.008% and 0.03% (BS1). The variant is observed in at least 2 individuals with no features of Rett Syndrome (BS2). -

not provided Benign:2
Apr 13, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 11309367, 16708070, 26755454, 28447035, 29206688) -

May 08, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Uncertain:1
Oct 10, 2016
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.P387L variant (also known as c.1160C>T), located in coding exon 3 of the MECP2 gene, results from a C to T substitution at nucleotide position 1160. The proline at codon 387 is replaced by leucine, an amino acid with similar properties. This variant was originally reported in a mentally retarded patient (Couvert P et al. Hum. Mol. Genet., 2001 Apr;10:941-6). In addition, this variant was identified in homozygosity in a female with clinical suspicion of Rett syndrome; however, it was also found in her unaffected father (Bhanushali AA et al. J Clin Neurosci, 2016 Mar;25:127-9). This variant was previously reported in the SNPDatabase as rs63390262. In the NHLBI Exome Sequencing Project (ESP), this variant was not observed in 6325 samples with coverage at this position. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. -

X-linked intellectual disability-psychosis-macroorchidism syndrome Uncertain:1
Apr 10, 2002
RettBASE
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: curation

- -

not specified Benign:1
Aug 22, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: MECP2 c.1160C>T (p.Pro387Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6.8e-05 in 1198205 control chromosomes (including 34 hemizygotes), predominantly at a frequency of 0.00025 within the South Asian subpopulation in the gnomAD database (v4.1.0). The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 30 fold of the estimated maximal expected allele frequency for a pathogenic variant in MECP2 causing Rett Syndrome phenotype (8.3e-06). c.1160C>T has been reported in a homozygous female suspected to have Rett syndrome (Bhanushali_2016), however, her father also carried the variant and was stated to be mentally normal. Additionally, the penetrance of Rett Syndrome (0.5) due to this variant appears to be lower than expected (0.8). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26755454, 11309367, 33452270). ClinVar contains an entry for this variant (Variation ID: 143383), which includes a benign classification from the ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel. Based on the evidence outlined above, the variant was classified as likely benign. -

Severe neonatal-onset encephalopathy with microcephaly Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Rett syndrome;C0796222:X-linked intellectual disability-psychosis-macroorchidism syndrome;C1845336:Autism, susceptibility to, X-linked 3;C1846058:Syndromic X-linked intellectual disability Lubs type;C1968556:Severe neonatal-onset encephalopathy with microcephaly Benign:1
Jan 03, 2022
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

MECP2-related disorder Benign:1
Apr 08, 2022
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.27
T;.
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Uncertain
0.91
D;D
M_CAP
Pathogenic
0.71
D
MetaRNN
Benign
0.21
T;T
MetaSVM
Uncertain
-0.20
T
MutationAssessor
Benign
0.0
N;.
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
0.43
N;N
REVEL
Uncertain
0.39
Sift
Uncertain
0.0050
D;D
Sift4G
Benign
0.21
T;T
Polyphen
0.42
B;P
Vest4
0.31
MVP
0.83
ClinPred
0.067
T
GERP RS
5.6
Varity_R
0.11
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs63390262; hg19: chrX-153296119; API